Johnson Financial Group Inc (Wisconsin)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Sell
17,190
-1,156
-6% -$162K 0.09% 113
2025
Q4
$2.25M Sell
18,346
-444
-2% -$54K 0.08% 116
2025
Q3
$2.09M Sell
18,790
-3,855
-17% -$438K 0.08% 118
2025
Q2
$2.51M Buy
22,645
+4,239
+23% +$451K 0.11% 102
2025
Q1
$2.06M Sell
18,406
-144
-0.8% -$14.9K 0.1% 108
2024
Q4
$1.8M Sell
18,550
-1,797
-9% -$162K 0.09% 114
2024
Q3
$1.71M Buy
20,347
+6,050
+42% +$462K 0.08% 121
2024
Q2
$981K Buy
14,297
+3,561
+33% +$238K 0.05% 147
2024
Q1
$786K Sell
10,736
-2,055
-16% -$158K 0.04% 141
2023
Q4
$1.04M Sell
12,791
-501
-4% -$39K 0.06% 110
2023
Q3
$996K Buy
13,292
+755
+6% +$58.1K 0.07% 110
2023
Q2
$966K Buy
12,537
+130
+1% +$10.4K 0.07% 125
2023
Q1
$1.03M Sell
12,407
-1,051
-8% -$87K 0.07% 113
2022
Q4
$1.16M Buy
13,458
+379
+3% +$30K 0.09% 104
2022
Q3
$1.02M Sell
13,079
-4,017
-23% -$253K 0.09% 102
2022
Q2
$1.06M Sell
17,096
-371
-2% -$23K 0.08% 112
2022
Q1
$1.04M Buy
17,467
+100
+0.6% +$6.39K 0.07% 130
2021
Q4
$1.26M Buy
17,367
+11,438
+193% +$788K 0.08% 115
2021
Q3
$414K Sell
5,929
-1,015
-15% -$71.3K 0.03% 196
2021
Q2
$478K Buy
6,944
+524
+8% +$35K 0.03% 191
2021
Q1
$415K Sell
6,420
-9,989
-61% -$644K 0.03% 196
2020
Q4
$956K Sell
16,409
-7,847
-32% -$473K 0.08% 111
2020
Q3
$1.53M Buy
24,256
+1,826
+8% +$127K 0.16% 72
2020
Q2
$1.73M Sell
22,430
-2,215
-9% -$170K 0.19% 64
2020
Q1
$1.84M Buy
24,645
+2,561
+12% +$177K 0.22% 58
2019
Q4
$1.44M Sell
22,084
-17,074
-44% -$1.11M 0.13% 85
2019
Q3
$2.48M Buy
39,158
+127
+0.3% +$8.3K 0.23% 67
2019
Q2
$2.64M Sell
39,031
-4,324
-10% -$284K 0.23% 62
2019
Q1
$2.82M Buy
43,355
+2,615
+6% +$174K 0.25% 60
2018
Q4
$2.55M Sell
40,740
-4,175
-9% -$292K 0.26% 61
2018
Q3
$3.47M Sell
44,915
-397
-0.9% -$30K 0.35% 47
2018
Q2
$3.21M Sell
45,312
-3,390
-7% -$239K 0.35% 48
2018
Q1
$3.67M Buy
48,702
+6,207
+15% +$493K 0.44% 43
2017
Q4
$3.04M Buy
42,495
+4,634
+12% +$352K 0.37% 54
2017
Q3
$3.07M Sell
37,861
-8,419
-18% -$644K 0.4% 47
2017
Q2
$3.28M Buy
46,280
+11,768
+34% +$783K 0.47% 42
2017
Q1
$2.34M Buy
34,512
+598
+2% +$42K 0.3% 79
2016
Q4
$2.43M Sell
33,914
-241
-0.7% -$17.9K 0.33% 70
2016
Q3
$2.7M Buy
34,155
+319
+0.9% +$25.9K 0.36% 63
2016
Q2
$2.82M Buy
33,836
+4,766
+16% +$423K 0.39% 62
2016
Q1
$2.67M Buy
29,070
+3,939
+16% +$355K 0.53% 45
2015
Q4
$2.54M Buy
25,131
+3,007
+14% +$313K 0.53% 41
2015
Q3
$2.17M Buy
22,124
+1,272
+6% +$141K 0.48% 49
2015
Q2
$2.44M Sell
20,852
-36
-0.2% -$3.93K 0.51% 46
2015
Q1
$2.05M Buy
20,888
+399
+2% +$40.5K 0.44% 55
2014
Q4
$1.93M Buy
20,489
+798
+4% +$82.5K 0.45% 53
2014
Q3
$2.1M Sell
19,691
-3,354
-15% -$328K 0.55% 44
2014
Q2
$1.91M Buy
23,045
+5,790
+34% +$451K 0.5% 48
2014
Q1
$1.22M Buy
17,255
+473
+3% +$37.1K 0.36% 74
2013
Q4
$1.26M Sell
16,782
-1,305
-7% -$90.9K 0.36% 68
2013
Q3
$1.14M Sell
18,087
-1,778
-9% -$106K 0.34% 66
2013
Q2
$1.02M Buy
+19,865
New +$1.04M 0.28% 67

Other funds holding GILD

Johnson Financial Group Inc (Wisconsin)'s GILD Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) reduced its Gilead Sciences (GILD) stake by 6.3% in Q1 2026, selling an estimated $162K and leaving 17,190 shares worth $2.4M. The position accounts for 0.09% of the portfolio, ranked #113.

Johnson Financial Group Inc (Wisconsin) first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.67M in Q1 2018. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 17,190 shares of Gilead Sciences worth $2.4M as of Q1 2026.
  • Johnson Financial Group Inc (Wisconsin) sold 1,156 Gilead Sciences shares in Q1 2026, an estimated $162K.
  • Gilead Sciences made up 0.09% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #113 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Gilead Sciences position peaked at $3.67M in Q1 2018.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.